Exhibit 107
Calculation of Filing Fee Tables
424(b)(5)
(Form Type)
Zentalis Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial effective date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||||||||||||||||
Fees to Be Paid | Equity | Common Stock, $0.001 par value per share | Rule 457(r) (1) | 11,032,656 | $22.66 | $249,999,985.96 | 0.00011020 | $27,550.00 | - | - | - | - | ||||||||||||||||||||||||||
Fees Previously Paid | ||||||||||||||||||||||||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||||||||||||||||
Carry Forward Securities | - | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||
Total Offering Amounts | $249,999,985.96 | $27,550.00 | ||||||||||||||||||||||||||||||||||||
Total Fees Previously Paid | - | |||||||||||||||||||||||||||||||||||||
Total Fee Offsets | - | |||||||||||||||||||||||||||||||||||||
Net Fee Due | $27,550.00 |
(1)Calculated in accordance with Rule 457(r) under the Securities Act of 1933, as amended. Represents deferred payment of the registration fees in connection with the registrant’s Registration Statement on Form S-3ASR (Registration No. 333-255769) being paid herewith.
1